Dr Agarwals Eye Hospital Limited
Dr Agarwals Eye Hospital Limited (DRAGARWQ): company summary
The company's business is growing, with annual revenue rising 24.5% and annual net profit increasing 19.6%.
Dr Agarwals Eye Hospital Limited (DRAGARWQ) is a micro-cap Healthcare company valued at ₹2,465 crore operating in Hospital on the NSE and BSE.
- Recent price move
- Dr Agarwals Eye Hospital Limited last traded at ₹5,170, modestly up 0.43% on the day.
- Recent developments
- On 2026-09-02, the company announced a dividend of ₹4.00 per share, ex-date. The domestic institutional holding decreased by 0.07 percentage points in the latest quarter.
- Financial performance
- The company's business is growing, with annual revenue rising 24.5% and annual net profit increasing 19.6%. The latest quarter saw revenue rise 22.2% and net profit jump 35.3% compared to the same quarter a year earlier, though the net profit margin narrowed slightly to 13.9% from 14.4%.
- Valuation multiples
- The stock trades at 44.5 times earnings, a premium to the Healthcare median of 32.0, 7.42 times book value. It yields 0.1%.
- Things to watch
- The stock is 14.9% below its 52-week high, and the net profit margin has narrowed by 0.6 percentage points. The debt to equity ratio stands at 1.59, indicating a moderate level of leverage.
- Where it stands
- Dr. Agarwal's Eye Hosp L has shown strong growth in both revenue and net profit over the past year and quarter, with a notable rise in net profit. The stock remains below its 52-week high, and the net profit margin has slightly declined, which is the most significant reported figure.
Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by growth (9.5) and quality (7.9), but held back by valuation (0.1). Growth looks strong at 9.5, but that is offset by valuation at 0.1. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Profitable in all of the last 5 years
- Revenue compounding 27% a year
- Strong returns on equity (26%)
- High leverage — debt is 1.6× equity
- Valuation is weak (0.1/10)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Hospital
Explore Dr Agarwals Eye Hospital Limited’s valuation
Free deep-dive tools · no sign-up
Dr Agarwals Eye Hospital Limited peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Compare Dr Agarwals Eye Hospital Limited with peers
Related tools & concepts
Value Dr Agarwals Eye Hospital Limited with the ratios and calculators DocStoX uses in its analysis.

